Clinical trial Recruiting at 1 site Observational Ages 18 and up

Evaluating a scoring system for postoperative ileus in digestive surgery

Official title: Study of Postoperative Ileus in Digestive Surgery

Run by University Hospital, Toulouse · NCT06018961 · Data updated 2026-11-12

This study is testing a new scoring system to see if it can help doctors better understand and manage postoperative ileus in patients after colorectal surgery.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment161 (estimated)
SponsorUniversity Hospital, Toulouse
Academic / other
Drugs / interventionschemotherapy
Locations2 sites (Toulouse and 1 other locations)
StatusRecruiting
StartedApril 24, 2024
Main results expectedJune 15, 2026
Study endsJune 15, 2026
Registry record updatedDecember 31, 2025
Trial IDNCT06018961 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients scheduled for surgical management of colorectal cancer, chronic inflammatory bowel disease, or colonic diverticulosis.

Probably not a fit

Patients with complex surgical needs, such as those requiring emergency surgery or with multiple digestive resections, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on postoperative ileus, a common complication following colorectal surgery characterized by a temporary cessation of bowel function. The primary aim is to evaluate the IFEED score, a clinical tool proposed to define and assess postoperative ileus, and to compare its effectiveness with the length of hospital stay. By analyzing a cohort of patients undergoing digestive tract surgeries, the study seeks to establish a reproducible definition of ileus and improve patient management. The research is being conducted at a single center, the University Hospital in Toulouse.

Why it matters

Potential benefit: If successful, this study could lead to better definitions and management strategies for postoperative ileus, potentially reducing hospital stays and improving patient outcomes.

How similar studies have gone: While the IFEED score has been proposed, this study is novel as it aims to evaluate it prospectively in a patient cohort.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient entering our care sector for surgical management of a pathology affecting the digestive tract:
* Colorectal cancer
* Chronic inflammatory bowel disease
* Colonic diverticulosis.

Exclusion Criteria:

* Patient treated for digestive resection with associated resection procedure or to be treated with intraperitoneal chemotherapy.
* Patient presenting during hospitalization with an ileus secondary to another intra-abdominal complication.
* Patient cared for in an emergency
* Hepatic resection or other associated metastatic site
* Multiple digestive resection
* Colorectal anastomosis less than 7 cm from the anal margin (below the Pouch of Douglas)
* Patient with American Society of Anesthesiologists physical status (ASA) score \> 2
* Patient with an Eastern Cooperative Oncology Group (ECOG) Performance Status Scale \>2
* Pregnant or breastfeeding women
* Patient under a protection regime for adults (guardianship, curators, safeguard of justice)

Where it's running

  • CHU de Toulouse
    Toulouse, France
    Recruiting
  • Inserm
    Toulouse, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.